Appendix cancer other diagnostic studies
|
Appendix cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Appendix cancer other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Appendix cancer other diagnostic studies |
|
Risk calculators and risk factors for Appendix cancer other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
- Appendix cancer may also be diagnosed using scintigraphy, Capsule endoscopy, Enteroscopy, Positron emission tomography (PET). Chromogranin A (CgA) and 5-HIAA (5-hydroxyindoleacetic acid) are among biochemical markers that might represent level of malignant cells activity in carcinoid syndrome.
Other Diagnostic Studies
- Appendix cancer may also be diagnosed using the following diagnostic studies:
- Somatostatin scintigraphy with 111-indium-octreotide
- Bone scintigraphy with 99mTc-methylene diphosphonate (99mTcMDP)
- Capsule endoscopy
- Enteroscopy
- Positron emission tomography (PET)
- The following are among biochemocal markers that might represent level of malignant cells activity in carcinoid syndrome.
References
- ↑ Eriksson B, Oberg K, Stridsberg M (2000) Tumor markers in neuroendocrine tumors. Digestion 62 Suppl 1 ():33-8. DOI:10.1159/000051853 PMID: 10940685
- ↑ Oberg K, Janson ET, Eriksson B (1999) Tumour markers in neuroendocrine tumours. Ital J Gastroenterol Hepatol 31 Suppl 2 ():S160-2. PMID: 10604122